CPC Scientific

CDMO specializing in large-scale, late-phase, and commercial GMP peptide and oligonucleotide manufacturing. Annual peptide API production capacity exceeds 1,000 kg. Serves clinical and commercial pharmaceutical clients. New US-based facility opening 2026. Maintains global shipping logistics for multi-kg batches.

CPC Scientific is listed as a CDMO in the peptide supply chain, serving Global markets from USA / China. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 2 independent sources, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.